A Safety, Tolerability, Efficacy and Exposure Study of XEN801 Topical Gel
Clinical trial NCT02656043 · COMPLETED
Trial details
- NCT number
- NCT02656043
- Sponsor
- Xenon Pharmaceuticals Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-17
- Primary completion
- 2017-02-16
- Enrollment
- 213
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.